Cita APA

Cui, D., Dai, J., Keller, J. M., Mizokami, A., Xia, S., & Keller, E. T. (2015). Notch pathway inhibition using PF-03084014, a γ-secretase inhibitor (GSI), enhances the anti-tumor effect of docetaxel in prostate cancer. Clin Cancer Res.

Citación estilo Chicago

Cui, Di, Jinlu Dai, Jill M. Keller, Atsushi Mizokami, Shujie Xia, y Evan T. Keller. "Notch Pathway Inhibition Using PF-03084014, a γ-secretase Inhibitor (GSI), Enhances the Anti-tumor Effect of Docetaxel in Prostate Cancer." Clin Cancer Res 2015.

Cita MLA

Cui, Di, et al. "Notch Pathway Inhibition Using PF-03084014, a γ-secretase Inhibitor (GSI), Enhances the Anti-tumor Effect of Docetaxel in Prostate Cancer." Clin Cancer Res 2015.